CeQur Simplicity: A Game Changer in Mealtime Insulin Delivery
In a significant advancement for diabetes care, CeQur® has recently announced the national availability of its Simplicity wearable insulin patch. Designed to simplify mealtime insulin delivery, this innovative device allows for up to seven days of continuous wear and introduces a new 1-unit dosing option, enhancing flexibility in diabetes management.
The Need for Change
According to a recent CeQur/Harris Poll,
51% of adults in the U.S. who use mealtime insulin via traditional methods like pens or syringes report missing doses. The struggles associated with managing mealtime insulin often extend beyond the medical aspect, affecting individuals' daily responsibilities and overall well-being. For many, the inconvenience of carrying supplies and finding a suitable place to inject creates barriers to adhering to their treatment regimens.
Statistics Highlighting the Issue
- - Missed Doses: 51% of diabetes patients using injectable insulin have skipped or missed doses.
- - Public Access Challenges: 70% of those who missed doses cited being in public settings as a crucial factor.
- - Emotional Impact: The struggle to manage mealtime insulin has been linked to:
-
Decreased job performance (61%)
-
Adverse effects on psychological well-being (54%)
-
Challenges in fulfilling daily responsibilities (49%)
-
Negative impacts on social interactions (45%)
Despite the knowledge that insulin is essential for their management, the complexities of life often lead individuals to forgo their medication.
Introducing CeQur Simplicity
CeQur Simplicity offers a practical solution to these challenges. This patch can be worn discreetly on the abdomen, upper arm, or thigh, allowing individuals to receive their insulin doses without the need for cumbersome pens or needles. This convenience is made possible through its design that not only ensures easy application but also maintains discretion in social situations.
Unique Features of CeQur Simplicity
- - Extended Wear: Patients can wear the patch for up to seven days, which means far fewer interruptions in their routines compared to daily injections.
- - Flexible Dosing Options: With both 1-unit and 2-unit dosing options, healthcare professionals can tailor the insulin delivery to fit individual patient needs.
- - Ease of Use: Administering insulin requires just a click, which simplifies the process significantly, making it easier for users to keep up with their treatment.
Jennifer Goldman, PharmD, CDCES, highlighted the profound impact of mealtime insulin management on patients' lives, emphasizing how it can dominate daily activities. With CeQur Simplicity, patients can leave behind the worries of managing their mealtime insulin injections, allowing them to focus more on their daily lives and less on their treatment regimen.
Conclusion
For those managing diabetes, incorporating the CeQur Simplicity patch into their routine can provide a much-needed reprieve from the monotonous cycle of injections, freeing them to fully engage with their lives. Patients are encouraged to discuss this innovative treatment option with their healthcare providers. For further details on the CeQur Simplicity, visit
MyCeQurSimplicity.com.
By embracing new technologies, the future of diabetes management looks brighter for many.
About CeQur
CeQur specializes in developing user-friendly insulin delivery devices, aiming to enhance the quality of life for individuals living with diabetes through innovative solutions that prioritize ease of use and effective therapy adherence.